Form 4 for RMD ResMed|
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-10 · accession 0001127602-24-018379 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-11 | 2024-06-10 | RMD | Sandercock Brett | CFO | S - Sale | $209.81 | -1,000 | 91.1K | -1% | -$209.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-06-10 | S | D | 1,000 | $209.81 | 91,056 | D | — | — | (F2) Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan. |